S. 2061

119 S2061 IS: Molly R. Loomis Research for Descendants of Toxic Exposed Veterans Act of 2025
 U.S. Senate
 2025-06-12
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 II  119th CONGRESS  1st Session  S. 2061  IN THE SENATE OF THE UNITED STATES   June 12, 2025   Mr. Blumenthal  (for himself and  Mrs. Murray ) introduced the following bill; which was read
        twice and referred to the  Committee on Veterans'
 Affairs    A BILL
To require the Interagency Working Group on Toxic Exposure to conduct research on the diagnosis and treatment of health conditions of descendants of individuals exposed to toxic substances while serving as members of the Armed Forces, and for other purposes.
1.
Short title
This Act may be cited as the   Molly R. Loomis Research for Descendants of Toxic Exposed Veterans Act of 2025  .
2.
Research on diagnosis and treatment of health conditions of descendants of individuals exposed to toxic substances while serving in Armed Forces
(a)
In general
Subsection (b) of section 501 of the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act of 2022 ( Public Law 117–168 ) is amended by adding at the end the following new paragraph:
(3)
Establish Federal interagency task forces to conduct collaborative research activities.
 .
(b)
Reporting
Subsection (c) of such section is amended by striking paragraphs (2) and (3) and inserting the following:
(2)
Not later than one year after the date of the enactment of the  Molly R. Loomis Research for Descendants of Toxic Exposed Veterans Act of 2025 —
(A)
a report containing a description of the collaborative research activities identified by the Working Group under subsection (b);
(B)
the findings of the members of the Working Group with respect to the collaborative research activities described in subparagraph (A); and
(C)
such recommendations as the Working Group may have for legislative or administrative action to improve collaborative research activities among the members of the Working Group.
(3)
Not less frequently than annually during the five-year period covered by the strategic plan developed under subsection (b)—
(A)
a summary of the collaborative research activities carried out by the members of the Working Group and the findings of the members with respect to such research activities;
(B)
a progress report on implementation of the strategic plan developed by the Working Group under subsection (b); and
(C)
such recommendations as the Working Group may have for legislative or administrative action to improve collaborative research activities among members of the Working Group.
 .
(c)
Research requirements
Such section is amended—
(1)
by redesignating subsections (c) through (e) as subsections (d) through (f), respectively;
(2)
in subsection (e), as redesignated by paragraph (1), by striking  under subsection (c)  and inserting  under subsection (d) ; and
(3)
by inserting after subsection (b) the following new subsection (c):
(c)
Requirements relating to certain research on impacts to descendants
Not later than 180 days after the date of the enactment of the  Molly R. Loomis Research for Descendants of Toxic Exposed Veterans Act of 2025 , the Working Group and the Agency for Toxic Substances and Disease Registry shall—
(1)
establish an interagency task force to conduct research on the diagnosis and treatment of health conditions of descendants of toxic-exposed veteran (as defined in section 101 of title 38, United States Code); and
(2)
maintain a publicly available website with information on the activities and findings of the Agency under paragraph (1), including a review of all relevant data to determine the strength of evidence for a positive association between a health condition researched and a toxic exposure risk activity (as defined in section 1710(e)(4) of title 38, United States Code) based on the categories set forth under section 1173(c)(2) of title 38, United States Code.
 .